Your session is about to expire
← Back to Search
Health Coaching + Home Monitoring for Postpartum High Blood Pressure (STAC-MyHEARTp Trial)
N/A
Recruiting
Led By Kara K Hoppe, DO
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Genetically female
Patients who complete the 6-week program, had a hypertension disorder of pregnancy with persistent hypertension (systolic blood pressure > 130 mmHg or diastolic blood pressure > 80 mmHg) and/or are still on antihypertensive medication, and those with chronic hypertension (CHTN)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
STAC-MyHEARTp Trial Summary
This trial will study if health coaching can improve postpartum care, hypertension control and self-management in 140 participants over 12 months.
Who is the study for?
This trial is for postpartum patients with high blood pressure, either persistent from pregnancy or chronic. Participants must be willing to follow the study procedures for 12 months, have completed a 6-week program, and not planning any major medical treatments or other clinical trials that could interfere. They should not be pregnant nor planning pregnancy within the year.Check my eligibility
What is being tested?
The STAC and MyHEART programs are being tested to see if health coaching alongside home blood pressure monitoring can improve care attendance, control of hypertension, and self-management behaviors in postpartum women with high blood pressure compared to usual care.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like health coaching and home monitoring rather than drugs or invasive procedures, side effects are minimal but may include potential stress or anxiety related to self-monitoring and lifestyle changes.
STAC-MyHEARTp Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am genetically female.
Select...
I completed a 6-week program and still have high blood pressure or take medication for it.
Select...
I am willing and able to follow all study rules and attend all appointments.
Select...
I am willing and able to sign a consent form.
STAC-MyHEARTp Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants Who Attend 12 month Postpartum Care Visit
Secondary outcome measures
Change in Body Mass Index (BMI)
Change in Home Blood Pressure Monitoring Frequency
Change in Weight (kg)
+9 moreSTAC-MyHEARTp Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Health CoachingExperimental Treatment2 Interventions
Group II: Standard of CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,177 Previous Clinical Trials
3,012,022 Total Patients Enrolled
UnityPoint Health-Meriter FoundationUNKNOWN
1 Previous Clinical Trials
60 Total Patients Enrolled
Kara K Hoppe, DOPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
105 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with sickle cell anemia or cystic fibrosis.I cannot or do not want to travel to the clinic for study visits.I am genetically female.I completed a 6-week program and still have high blood pressure or take medication for it.You have fainted while exercising or doing strenuous activity in the last 12 months.I do not have a history of high blood pressure.I am currently undergoing dialysis or seeing a kidney specialist.I am willing and able to follow all study rules and attend all appointments.I have not had chemotherapy or radiation in the last 6 months.I cannot read or communicate in English.I am currently taking warfarin, a new oral anticoagulant, or insulin.I have had a stroke, heart attack, or heart surgery in the last 2 years.I have had an organ transplant in the last 5 years or am planning one.You have a health condition that will make it hard for you to exercise more and change your diet.I am willing and able to sign a consent form.You have used illegal drugs, except for marijuana, in the last 30 days.The difference in blood pressure between your arms is more than 20 mmHg.I have been diagnosed with Congestive Heart Failure.I am able to give my own consent for treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Health Coaching
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to participate in the trial?
"As recorded on clinicaltrials.gov, this study has ceased patient recruitment as of January 5th 2023 after first being posted on February 1st 2023. However, there are 729 other trials that are presently welcoming patients to participate in their research."
Answered by AI
Who else is applying?
What state do they live in?
Wisconsin
What site did they apply to?
UW Hospital and Clinics
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger